This review examines the pharmacological treatment options for women's sexual dysfunction, focusing on therapies targeting reduced sexual desire and arousal. Local estrogen therapy has been shown to improve genital vasocongestion and alleviate symptoms of vulvar and vaginal atrophy, while phosphodiesterase inhibitors may benefit women with autonomic neuropathies. Intravaginal DHEA, which
